Early clinical trial reports results in this hidden disease

Two Novartis leaders share their perspectives on digital health in 2020 – and the key trends to watch out for over the next 12 months.

After being diagnosed with an aggressive form of leukemia, Ilana Massi defied the odds with the help of her friends and family.

New Global Head of Business Development and Licensing for research makes connections naturally, decisions scientifically.

NIBR investigator develops technology that uses tumor DNA in the blood for diagnostics

Bioengineers, immunologists and clinicians collaborate to explore a new approach to fighting cancer.

The recently appointed leader of the Novartis’ digital research and development platform data42 is a strong believer that data and digital technologies will change the path of medical science.

Novartis team perseveres to develop more personalized approach to breast cancer therapy.

Novartis is investing in a novel type of medicine to reduce the risk of heart disease.